Such pattern of expression suggested that SIRT2 is upregulated in well-perfused regions of 9L gliomas, whereas the expression of SIRT2 in hypoxic-appearing regions is significantly reduced, which was confirmed immunohistochemically by presence of HIF-1α-expression in the same regions in adjacent tissue sections. The gene discussed is SIRT2; the disease is central nervous system cancer.